Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:13 PM
Ignite Modification Date:
2025-12-24 @ 11:13 PM
NCT ID:
NCT05631769
Eligibility Criteria:
* Inclusion Criteria:
1. The patient agrees to participate in this study by signing the informed consent form. Alternatively, a legally authorized patient representative may agree to the patient's participation in this study and sign the informed consent form.
2. The patient in whom the Bleeding Risk (according to the ARC-HBR classification) can be calculated.
3. The patient has a working diagnosis of coronary artery disease which has been treated with percutaneous coronary intervention.
* Exclusion Criteria:
1. Hypersensitivity to aspirin or P2Y12 inhibitors
2. Patients in whom coroanry artery disease has been decided to be medically managed without a coronary stent.
3. Positive pregnancy test or is known to be pregnant
4. Any other reason the investigator deems the subject to be unsuitable for the study (e.g., Any life-threatening condition with life expectancy less than 6months, etc.)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT05631769
Study Brief:
Protocol Section:
NCT05631769